Log In
BCIQ
Print this Print this
 

Ocplex, Pronativ (octaplex)

  Manage Alerts
Collapse Summary General Information
Company Octapharma AG
DescriptionFreeze-dried human prothrombin complex
Molecular Target
Mechanism of ActionReverse anticoagulant
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsReversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure
Regulatory Designation U.S. - Fast Track (Reversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure);
U.S. - Orphan Drug (Reversal of anticoagulation therapy in patients receiving vitamin K antagonist therapy in need of urgent surgery or invasive procedure)
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/16/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today